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Abstract
Nipah virus (NiV) is a recently emerged zoonotic Paramyxovirus that causes regular outbreaks in East Asia with mortality rate
exceeding 75%. Major cellular targets of NiV infection are endothelial cells and neurons. To better understand virus-host
interaction, we analyzed the transcriptome profile of NiV infection in primary human umbilical vein endothelial cells. We
further assessed some of the obtained results by in vitro and in vivo methods in a hamster model and in brain samples from
NiV-infected patients. We found that NiV infection strongly induces genes involved in interferon response in endothelial
cells. Among the top ten upregulated genes, we identified the chemokine CXCL10 (interferon-induced protein 10, IP-10), an
important chemoattractant involved in the generation of inflammatory immune response and neurotoxicity. In NiV-infected
hamsters, which develop pathology similar to what is seen in humans, expression of CXCL10 mRNA was induced in different
organs with kinetics that followed NiV replication. Finally, we showed intense staining for CXCL10 in the brain of patients
who succumbed to lethal NiV infection during the outbreak in Malaysia, confirming induction of this chemokine in fatal
human infections. This study sheds new light on NiV pathogenesis, indicating the role of CXCL10 during the course of
infection and suggests that this chemokine may serve as a potential new marker for lethal NiV encephalitis.
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Introduction
Nipah virus (NiV) is a recently emerged zoonotic pathogen of
the family Paramyxoviridae that is distinguished by its ability to
cause fatal disease in both animals and humans. NiV along with
Hendra virus (HeV) comprise the new genus Henipavirus
(reviewed in [1]). NiV was first identified during an outbreak of
severe encephalitis in Malaysia and Singapore in 1998–99, with
pigs serving as the intermediate amplifying host [2]. Since 1998
NiV has caused regular outbreaks, primarily in Bangladesh and
India, with the most recent occurrences at the beginning of 2011
[3]. In the majority of subsequent spillover events, the mortality
rate among humans has been higher (,75%) along with evidence
of multiple rounds of person-to-person transmission [4,5,6].
The endothelial cells represent one of the major targets of NiV
infection, whichis characterizedby a systemic vasculitis and discrete
parenchymal necrosis and inflammation in most organs, particu-
larly in the central nervous system (CNS). The high pathogenicity of
NiV infection appears to be primarily due to endothelial damage,
syncytia and vasculitis-induced thrombosis, ischemia and vascular
microinfarction in the CNS, allowing the virus to overcome the
blood-brain-barrier (BBB) and to subsequently infect neurons and
glia cells in the brain parenchyma [2,7].
Pathogenesis of NiV infection is still poorly understood. As the
endothelium forms the primary barrier of the circulatory system,
endothelial dysfunction during infection could broadly affect immune
cell function by regulating cytokines, chemokines and cell receptors
and influencing vascular permeability. To gain new insights into
virus-host interaction, we analyzed the transcriptome signature of
NiV infection in primary human umbilical vein endothelial cells
(HUVECs). Among the ten most strongly upregulated genes 8 h after
NiV infection, we identified CXCL10 (interferon gamma-induced
protein 10, IP-10), a chemokine that promotes leukocyte trafficking
by acting on T lymphocytes, NK and dendritic cells via its receptor
CXCR3 [8]. In addition to its protective role during the viral
infection, CXCL10 may enhance the severity of virus infection and
cause neuronal apoptosis and calcium dysregulation [9,10] and
enhance autoreactive lymphoproliferation and brain injury [11]. We
have confirmed secretion of CXCL10 by NiV-infected HUVECs by
ELISA and showed that increased production of CXCL10 follows
NIV replication in experimentally infected hamsters. Finally, we
demonstrated production of CXCL10 in brain endothelial cells of
patients with fatal acute NiV encephalitis. Altogether, these results
suggestthatCXCL10maybeanimportantregulatorofNiV-induced
pathogenesis as well as a potential marker for NiV infection.
Results
Primary human endothelial cells are highly permissive to
Nipah virus infection
As endohelial cells are the first target of NiV infection, we have
initially studied a permissivity of HUVEC cultures to NiV
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32157infection. We established the HUVEC cell culture and assessed
their purity at passage 2, either by cell immunostaining or flow
cytometry using two endothelial-specific markers, Von Willebrand
Factor (VWF) stored in cytoplasmic Weibel-Palade bodies, and
CD31 (PECAM-1) localized in homophilic intercellular contacts,
which gave us reproducibly satisfactory results (Fig. S1). We then
analyzed the expression of NiV receptors, production of viral
specific RNAs, generation of the cytopatic effect and production of
viral particles (Fig. 1). The expression of mRNA specific for NiV
entry receptors ephrinB2 and B3 [12,13,14] was readily detected
in these cells, at levels close to those in the astroglioma cell line
U373, which was also highly permissive to NiV infection [15]
(Fig. 1C). Production of NiV structural genes coding for
nucleoprotein, matrix, fusion protein, glycoprotein and polymer-
ase increased rapidly during the infection, following a gradient
characteristic of paramyxoviruses, with highest expression of the
first gene represented in the genome, N, and lowest for the gene
coding for the polymerase (Fig. 1D). Formation of large syncytia
was rapidly detected in HUVECs (Fig. 1B) and the highest level of
the production of infectious particles was obtained 24H after
infection, as most of the cells were lysed 48 h p.i. in this cell type
(Fig. 1E). Therefore, NiV infects rapidly HUVECs and induces a
significant cytopathic effect.
Microarray analysis of NiV infection in HUVECs
To better understand virus-host interaction, we have analysed
the effect of NiV infection at the level of gene expression in
HUVECs, using Codelink microarray (see Materials and Meth-
ods). Cells were infected with either NiV or treated with mock
preparation and RNA was taken 8 h p.i., to obtain the information
about the early changes in NiV-induced gene expression in
HUVEC in the conditions when cell viability was still preserved.
Among 55.000 analyzed genes, pair-wise comparisons between
infected and uninfected samples revealed 807 deregulated genes
(fold change cut-off=1.3). NiV infection down-regulated galectin
3 gene expression, a member of the lectin family, involved in cell
adhesion, cell activation and chemoatraction [16], but most of the
other down-regulated genes were not found associated with any
known function (table 1). The 538 up-regulated genes were
classified according to their Gene Ontology (GO) biological
processes and molecular functions. This analysis revealed that
NiV-infection up-regulated 34 genes implicated in the immune
response, particularly those associated with the interferon
pathway, including MxA, RIGI, MDA, 2959-OAS 1 and 2
(Fig. 2). Interestingly, among the top ten up-regulated genes was
CXCL10 (interferon gamma-induced protein 10, IP10), an
important chemokine secreted by endothelial cells (table 1). These
results have been further confirmed by RT-qPCR at 8 and 24 h
post-infection for several genes linked to interferon pathway,
including MXA, OAS1, IFN beta and CXCL10 (Fig. 3A). In
addition to stimulation of CXCL10, which was observed at
different MOI of infection, MOI of 1 as well as 3, the induction of
the closely related chemokine CXCL11 (Interferon-inducible T-
cell alpha chemoattractant, I-TAC or IP-9), being at 19
th position
among up-regulated genes, was also confirmed by RT-qPCR
(Fig. 3A). However, the production of the third closely related
chemokine CXCL9 (MIG), which shares the same receptor
CXCR3 with CXCL10 and CXCL11, was not detected. Finally,
Figure 1. Primary human endothelial cells are highly permissive to NiV-infection. A, Mock-infected and B, NiV-infected HUVECs (MOI=1)
observed 24 h after infection show extensively developed syncytium formation. C, RT-qPCR analysis of the expression of NiV receptors ephrinB2
(EFNB2) and ephrinB3 (EFNB3) in HUVECs (black bars) and U373 astroglioma cells (white bars). D, Production of RNA specific for NiV genes:
nucleoprotein (N), matrix (M), fusion protein (F), glycoprotein (G) and polymerase (L) in HUVECs during infection, determined by RT-qPCR. Fold
change is relative to the number of copies of viral mRNAs 8 h or 24 h post infection compared to the number of copies obtained after 1 h of contact
with the virus. E, Production of infectious NiV particles during the course of infection; supernatants taken at different time points were titrated ona
Vero cell monolayer.
doi:10.1371/journal.pone.0032157.g001
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ed by ELISA up to 72 h of infection (Fig. 3B), confirming the NiV
infection induces the expression of CXCL10 at the protein level as
well.
Expression of CXCL10 mRNA follows NiV replication in
vivo
As CXCL10 is known to have an important immunobiological
function in the organism, which received a great deal of attention
in recent years, we focused further studies on this chemokine.
Thus, we analyzed whether NiV-infection induces production of
CXCL10 in vivo, using the hamster animal model, which closely
reproduces human infection and induces lethal outcome starting
from day 5 p.i. [17]. Hamsters were infected by NiV and sacrificed
on a daily basis for analysis of RNA in different organs (Fig. 4).
The baseline expression of CXCL10 was observed in all organs
and increased during the course of infection, particularly in brain
and kidney. In lung and spleen the level of CXCL10 initially
increased, but decreased on the last day that preceded lethal
outcome of the infection. The most rapid and highest induction of
CXCL10 mRNA expression was observed in the spleen (16 times
more than the baseline expression, already 24 h p.i.), which may
correlate with the abundance of cells capable of secreting
CXCL10 in the spleen (leukocytes, endothelial cells and splenic
stromal cells [18]. The highest NiV replication was observed in
lungs of infected hamsters. The level of CXCL10 expression
significantly correlated to the level of NiV N expression in
analysed organs (p,0.001), suggesting that production of this
chemokine closely follows the NIV replication.
CXCL10 is highly expressed in the brain of NiV infected
patients
We have next performed immunohistochemical analysis of
brain tissues from patients that succumbed to NiV-infection during
the outbreak in Malaysia in 1999. Widespread vasculitis and
perivascular infiltration were regularly detected after hematoxylin
Table 1. Genes most highly induced or inhibited in HUVEC cultures 8 h after NiV infection.
FC Common name GenBank N6 Description Function
23.3 PTPRM AI669006 protein tyrosine phosphatase, receptor type, M cellular growth and proliferation
23.2 MxA; IFI78; IFI-78K AF135187 myxovirus (influenza virus) resistance 1,
interferon-inducible protein p78
immune response
19.8 IFIT1; G10P1; IFI56; IFNAI1;
GARG-16
NM_001548 interferon-induced protein with
tetratricopeptide repeats 1
immune response
14.5 IFI44L; GS3686; C1orf29 NM_006820 interferon-induced protein 44-like immune response
14.2 BRESI1 NM_033255 epithelial stromal interaction 1 (breast) connective tissue disorder
11.6 MGC116903; MGC116904 NM_000811 gamma-aminobutyric acid (GABA) A receptor, alpha 6 neurological disease
11.4 cig5; vig1; 2510004L01Rik NM_080657 radical S-adenosyl methionine domain containing 2 viral function
10.9 CXCL10; IFI10; IP-10 NM_001565 chemokine (C-X-C motif) ligand 10 immune response
10.9 OASL; TRIP14 NM_003733 29-59-oligoadenylate synthetase-like immune response
10.8 RIG-G; IRG2; IFI60; ISG60;
GARG-49
NM_001549 interferon-induced protein with tetratricopeptide
repeats 3
immune response
10.4 IFIT2; G10P2; IFI54; GARG-39;
ISG-54K
NM_001547 interferon-induced protein with tetratricopeptide
repeats 2
immune response
10.3 OAS2; MGC78578 NM_002535 29-59-oligoadenylate synthetase 2, 69/71 kDa immune response
8.6 OAS1 AU076579 29,59-oligoadenylate synthetase 1, 40/46 kDa immune response
5.8 BAL; BAL1; NM_031458 poly (ADP-ribose) polymerase family, member 9 cellular movement
5.7 IFI44; p44; MTAP44 NM_006417 interferon-induced protein 44 immune response
25.4 LGALS3 AF031424 Homo sapiens galectin 3 (LGALS3) gene, exon 5. immune response
27.6 TAF4B AA457205 TAF4b RNA polymerase II, TATA box binding
protein ass factor, 105 kDa
cell signaling
28 ATP13A4 AW073336 ATPase type 13A4 unknown
210.3 BX108708 Transcribed locus unknown
212.3 IDS AK126415 CDNA FLJ44451 fis, UTERU2023039 unknown
213 BF476432 CDNA FLJ38408 fis, FEBRA2009029 unknown
214.8 AI255115 Transcribed locus unknown
217.9 CTS9 NM_017418 deleted in esophageal cancer 1 cancer
225.1 FLJ22318; DKFZp434K0926 NM_022762 hypothetical protein FLJ22318 unknown
232.1 MGC3035 NM_024293 chromosome 2 open reading frame 17 unknown
244 BBS4 BF370543 Bardet-Biedl syndrome 4 cancer
246.7 FLJ12986 AK126695 hypothetical protein FLJ12986 unknown
FC: Fold Change; induction of the level of gene expression in NiV-infected cells in comparison to mock-infected cells as determined by microarray analysis. Only
changes higher then 5.7 and lower then 25.4 are presented.
doi:10.1371/journal.pone.0032157.t001
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chemokine in brain endothelial cells (Fig. 5 B–F), as well as in
perivascular infiltrating cells (Fig. 5 G–H) and in occasional cells
with neuronal morphology (Fig. 5 E–F). CXCL10 expression was
intense in the endothelium of cerebral vessels in encephalitic
patients (Fig. 5 B–F) and was not observed in the cerebral cortex of
non-infected patients (Fig. 5A). Altogether, these results indicated
that NiV-infection activates cellular pathways leading to an
increase of CXCL10 expression that may play a role in the
pathogenesis of this highly lethal emergent infection.
Discussion
The inflammatory cellular infiltrates found in the CNS of
patients with acute NiV encephalitis include neutrophils, macro-
phages, lymphocytes and reactive microglia [7], which may all
play an important role in NiV pathogenesis. Recruitment of these
cells indicates a possible action of chemokines, known as main
regulators of leukocyte trafficking. Our analysis of the transcrip-
tome profile of NiV-infected primary endothelial cells revealed the
induction of several genes involved in the interferon type I
pathway as well as the overexpression of CXCL10, an important
chemoattractant chemokine with proinflammatory activity [19].
Although expression of IFN alpha and beta was shown to be
inhibited in human cell lines after NiV infection [20], human
primary endothelial cells seem to be resistant to this inhibition
[21]. Our study demonstrated that a few other members of
interferon type I pathway, including MxA, RIGI, 2959-OAS 1 and
2, are highly expressed early after NiV infection, suggesting a
functional interferon pathway in NiV-infected human endothelial
cells.
CXCL10 is a secreted polypeptide of 10 kDa that was first
identified as an early response gene induced after interferon
gamma treatment in a variety of cells, and was thus named
interferon gamma-inducible peptide, IP-10 [22,23]. Furthermore,
it was shown that interferon alpha could also induce CXCL10 in
primary cultured neurons [24] and seminiferous tubules [25]. In
addition to interferons, HIV envelope glycoprotein gp120 was
shown to induce expression of CXCL10 in brains of mice [26].
HIV Tat protein can also induce CXCL10 in astrocytes [27].
Furthermore, CXCL10 is expressed early in the CNS in response
to a wide variety of viruses [11,13,28,29,30]. Our results
demonstrate that NiV-infection induces rapidly production of
CXCL10 in primary endothelial cells. As production of interferon
gamma by these cells is contested, it is possible that the generation
of CXCL10 is either a direct effect of NiV proteins or is induced
Figure 2. Impact of NiV infection on interferon pathway in HUVEC cells, determined using Ingenuity Pathway Analysis. NiV-induced
upregulated genes are presented grouped, depending the cell compartment in which the corresponding proteins a localized (nucleus, cytoplasm,
plasma membrane and extracellular space, for secreted proteins). Level of FC increase is indicated bellow each gene and intensity of red color
corresponds to the FC.
doi:10.1371/journal.pone.0032157.g002
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over, our results demonstrate induction of CXCL10 in vivo in
different organs of NiV-infected hamsters, as well as in patients
that succumbed to lethal NiV-infection, thus revealing an
important association between NiV-infection and CXCL10
production. Although endothelial cells were clearly secreting this
chemokine, the perivascular inflammatory cells and some neurons
are most probably participating in the production of CXCL10 as
well.
Individual chemokines, including CXCL10, play opposing roles
in neuroinflammation in different experimental models of
infectious disease, making it difficult to predict whether they have
a protective role by contributing to immune eradication of the
microbial attack or they cause inflammatory damage and disease
[19]. Therefore, potential effect of CXCL10 in NiV infection
could be either beneficial or harmful and the balance between
these two effects may be critical for the final outcome of the
disease. Infection with RNA viruses that may cause encephalitis in
humans, such as HIV or lymphocytic choriomeningitis viruses, or
in rodent models, such as mouse hepatitis virus and Theiler’s virus,
can directly induce the expression of chemokines by astrocytes and
microglia and establish chemokine gradients that promote
leukocyte trafficking within the CNS [11,31,32,33]. In addition,
neutralization of CXCL10 decreased leukocyte migration to areas
Figure 3. Analysis of expression of interferon-related genes in NiV-infected HUVECs. A, RT-qPCR analysis of the expression of MXA, OAS1,
IFN beta, CXCL11 and CXCL10. B, ELISA analysis of the production of CXCL10 protein in mock-infected (white bars) and NiV-infected (black bars)
HUVC cultures. Results are expressed as the average of 2–3 individual experiments and bars represent standard deviation. *p,0.05, **p,0.01, Mann-
Whitney U-test.
doi:10.1371/journal.pone.0032157.g003
Figure 4. Expression of CXCL10 and NiV nucleoprotein (N) genes in organs obtained from NiV-infected hamsters during the course
of infection. Hamsters were sacrificed at different time points after infection and RNA was isolated from different organs and analyzed by RT-qPCR.
Grey bars correspond to CXCL10 and black bars to NiV-N, calculated as described in Methods. Significant correlation was found between expression
of CXCL10 and expression of NiV N (R
2=0,989, p,0,001, Pearson test).
doi:10.1371/journal.pone.0032157.g004
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several of these viruses directly infect neurons, these cells have not
been observed to participate in the inflammatory response,
suggesting the indirect induction of inflammatory response via
cytokines. Nevertheless, in a transgenic mouse model of measles
virus encephalitis, neuronal expression of CXCL10 was associated
with T-cell recruitment, suggesting that neurons may play a role in
the induction of immune responses to viral invasion [35]. In recent
study Lo et al. showed that NiV infection could induce production
of CXCL10 and several other inflammatory chemokines in
microvascular, but not in macrovascular endothelial cells [21].
However, in contrast to our study, they cultured endothelial cells
in the presence of hydrocortisone, known to have important anti-
inflammatory activity and to reduce the expression of pro-
inflammatory cytokines [36], which could account to the
differences with our results. In accord to our results, NiV was
shown to induce CXCL10 expression as well as several other
inflammatory chemokines in brain and lungs of NiV infected
hamsters [37] suggesting altogether that the other cytokines may
contribute to the CXCL10 proinflammatory effect.
Figure 5. Immunohistochemical analysis of CXCL10 production in the brain durng NiV infection. Non-infected patients (A, 6100) and
patients autopsied after lethal acute NiV-infection (B–H) were analysed for the expression of CXCL10 in endothelial cells in cerebral cortex (B, D,
61000, arrows) and cells with neuronal morphology (E, F). CXCL10 immunoreactivity in perivascular inflammatory cells (C, G, H, 6400).
doi:10.1371/journal.pone.0032157.g005
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individuals with HIV-1 infection [38,39] and in the brains of
individuals with HIV-associated dementia [33], but was absent in
uninfected control individuals. These authors also reported that
CXCL10 levels were closely associated with the progression of
HIV-1-related CNS infection and neuropsychiatric impairment.
Moreover, CXCL10 and its receptor CXCR3 were shown to be
present in the brains of macaques with SIV/SHIV-E [40,41] and
to elicit apoptosis in fetal neurons [9,42]. The mechanisms of
neuronal injury mediated by the CXCL10 was suggested to be
associated to calcium dysregulation during CXCL10 mediated
apoptosis [10], and we hypothesize that overexpression of
CXCL10 in Nipah-infected patients may be directly involved in
NiV-induced neuropathology. Lack of the appropriate regaents for
hamster animal model prevented us from further in vivo analysis of
the role of CXCL10 during Nipah infection.
CXCL10 is the substrate for serine protease CD26/dipeptidyl-
peptidase 4, which cleaves its aminoterminal part and alters its
receptor binding and signaling, producing therefore an antago-
nistic protein with dominant negative function [43]. This
antagonist form of CXCL10 was very recently shown to play an
important role in patients chronically infected with hepatitis C
virus [44] and to present an important negative prognostic marker
for the response to therapy [45,46]. Whether this cleaved
antagonist form of CXCL10 is generated during NiV-infection
remains to be elucidated. If produced, its action on inhibition of
the physiological role of CXCL10, may play an important role in
the pathogenesis of NiV-encephalitis.
These results suggest that NiV-infection in endothelial cells
induces CXCL10 production both in vitro and in vivo and highlight
the use of molecular profiling of virus-infected cells as a powerful
tool to define novel mechanisms of virus-host cell interaction. As
equilibrium in cytokine production is essential in the generation of
the adequate immune response, CXCL10 overexpression may be
crucial for the development of NiV-associated encephalitis and
could be a target for therapeutic approaches.
Materials and Methods
Ethics Statement
Umbilical cords were obtained between 2006 and 2008 from
healthy full-term newborns with written parental informed consent
according to the guidelines of the medical and ethical committees
of Hospices Civils de Lyon and of Agence de Biomedecine, Paris,
France. Ethics Committee approval for this study was not required
according to institutional guidelines and French law Nu2004-800,
from 6 August 2004 – art 12 ORF 7.08.2008, Article L1245-2,
allowing the utilization of the placenta and umbilical cords in
scientific and therapeutic purpose when their donors do not
express any opposition.
All animals were handled in strict accordance with good animal
practice as defined by the French national charte on the ethics of
animal experimentation. Animal work was approved by the
Regional ethical committee (Comite ´R e ´gional d’Ethique pour
l’Experimentation Animal de la Re ´gion Rhone-Alpes, CREEA,
protocol Nu 220) and experiments were performed in the
INSERM Jean Me ´rieux BSL-4 laboratory in Lyon, France
(French Animal regulation comitte ´e Nu A69 387 05 02).
Autopsies of human brain tissue were performed after receiving
written patient’s relatives consent for autopsy studies at the
Pathology Department of University of Malaya, Kuala Lumpur,
Malaysia and their analysis was approved by review board of
Faculty of Medicine of University.
Cell culture
Primary HUVECs were isolated from human umbilical cords
of 22 donors by treating the umbilical vein with 0.1%
collagenase for 30 min at 37uC as described previously [47].
Cell cultures were pooled by sets of three donors for
experiments. Cells were cultured in flasks coated with 0.2%
gelatin in complete medium containing M199 medium (Gibco),
20% of fetal calf serum (Gibco), 100 mg/ml bovine brain extract
[48], 14 mM Hepes (Gibco), 10 UI/ml heparin (Pfizer), and a
cocktail of antibiotic/antimycotic (Gibco). At passage 4, cells
were seeded at 30 000 cells/cm
2 for 8 h, then serum deprived
f o r1 6hp r i o rt oN i V - i n f e c t i o nin complete medium. Immuno-
fluorescent staining and analysis of HUVEC culture was
performed as described in Methods S1. U373 astroglioma and
Vero cells were maintained in DMEM medium (Invitrogen)
supplemented with 10% fetal calf serum, 100 U/ml penicillin,
0.1 mg streptomycin, 10 mM HEPES and 2 mM L-Glutamine
at 37uCi n5 %C O 2.
Infection of HUVECs and titration
Nipah virus (isolate UMMC1, Genebank AY029767) [49] was
prepared on Vero-E6 cells as described previously [50]. HUVECs
were infected with a multiplicity of infection (MOI) of 1 and
harvested for RNA isolation 8 and 24 hours post infection (p.i.). At
indicated times p.i. 150 ml of cell culture supernatant were
collected and frozen and viral titration was performed as detailed
elsewhere [50].
Infection of hamsters
Eight-week-old golden hamsters (Mesocricetus auratus, Janvier,
France) were anesthetized and infected intraperitoneally (i.p.) with
0.4 ml of wild-type NiV (10 000 PFU) in the BSL-4 laboratory in
Lyon. Each day post infection (p.i.), one hamster was euthanised
and organs were frozen at 280uC.
Microarray analysis
Total RNA was extracted from uninfected or NiV-infected
HUVECs 8 h p.i., both prepared from two different pools, each
containing 3 donors and cultured at same conditions, using
RNeasy kit (Qiagen) according to the manufacturer’s protocol.
Quality of total RNA was checked on nanochips with the Agilent
2100 Bioanalyzer 2100 (Agilent Technologies,).
Amplified and biotin-labeled RNAs were obtained from 2 mgo f
total RNA, by a round of in vitro transcription (dIVT) using the
Message Amp a RNA kit version II (Ambion), following the
manufacturer’s protocol. Different quantities of positive synthetic
mRNA controls (spikes, corresponding to 6 bacterial RNAs, used
to control sensitivity, quality of hybridization and data normali-
zation) were added to all samples, during the first step of reverse
transcription of total RNAs. Hybridization was performed on
Codelink Uniset Human Whole Genome bioarrays (http://www.
codelink bioarrays.com). 10 mg of biotin-labeled RNA were
fragmented using 5 ml fragmentation buffer in a final volume of
20 ml, then mixed with 240 ml Amersham hybridization solution
and injected onto Codelink Uniset Human Whole Genome
bioarrays, containing approximately 55.000 30-mer probes based
on the NCBI/Unigene RefSeq database that permit the
expression analysis of 57,347 transcripts and ESTs (GE Healthcare
Europe GmbH). Arrays were hybridized overnight at 37uC, then
washed in stringent TNT buffer at 46uC for 1 h before performing
a streptavidin-cy5 detection step. Each array was incubated for
30 min in 3,4 ml streptavidin-cy5 solution, washed four times in
240 ml TNT buffer, rinsed twice in 240 ml water containing
Nipah Virus Induction of CXCL10
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Arrays were then scanned at 635 nm using an Axon Genepix
4000B Scanner (Axon).
Data extraction and raw data normalization were performed
using the CodeLink Gene Expression Analysis v4.0 software.
Normalization was performed by the global method. The
threshold was calculated using the normalized signal intensity of
the negative controls supplemented by 3 times the standard
deviation. Spots with signal intensity below this threshold were
referred to as ‘‘absent’’. Obtained datasets were deposited in GEO
database in accord to MIAME guidelines (Accession number:
GSE 32902: GSM813064, GSM813065, GSM813066 and
GSM813067). Finally, data were converted to the excel format
and data analysis was performed by using the Gene Spring v7.0
software from Agilent and pariwise comparisons were performed
between infected and uninfected samples.
Quantitative reverse transcription PCR (RT-qPCR)
Total RNA was extracted from mock and NiV-infected
HUVECs 8 and 24 hours post-infection using RNeasy Mini Kit
according to the manufacturer’s instructions including additional
step with RNase-free DNase (Qiagen). RNA was isolated from
hamster organs 10–30 mg using a tissue lyser (Qiagen) in RLT
buffer containing 1% ß-mercaptoethanol, according to manufac-
turer recommendations.
Reverse transcriptions were performed on 0.5 mg of total RNA
using the Transcriptor first strand cDNA synthesis kit (Roche) and
run in BiometraH T-GRADIENT PCR devise. Obtained cDNAs
were diluted 1:10. Quantitative PCR was performed using
PlatinumH SYBRH Green qPCR SuperMix-UDG with ROX kit
(Invitrogen
TM). qPCR was run on the ABI 7000 PCR system
(Applied biosystems) using the following protocol: 95uC5 9, and 40
cycles of 95uC1 5 0,6 0 uC1 9, followed by a melting curve up to
95uC at 0.8uC intervals. All samples were run in duplicate and
results were analyzed using ABI Prism 7000 SDS software
available in the genetic analysis platform (IFR128 BioSciences
Lyon-Gerland). Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as housekeeping gene for mRNA quantifica-
tion and normalization. GAPDH and standard references for the
corresponding genes were included in each run to standardize
results in respect to RNA integrity, loaded quantity and inter-PCR
variations. Primers used were designed using Beacon 7.0 software,
and validated for their efficacy close to 100% in control PCR
amplification: EFN B2 for: TCGGGCTAGTTAAGGTGTGC,
EFN B2 rev: ATGAGTGTTCCATGAGTGATGC, EFN B3 for:
TCACCCTCTTGGCTTCTTATCC, EFN B3 rev: GGGGA-
GTGGTTGGTATGAGAG, NiV N for: GGCAGGATTCT-
TCGCAACCATC, NiV N rev: GGCTCTTGGGCCAATT-
TCTCTG, NiV L for: ATGGTGCTGTGCTGTCTCAGG,
NiV L rev: AGCCGACATTTCTTGACAACCC, IFNß for:
CTCCTAGCCTGTGCCTCTGG, IFNß rev: TGCAGTACAT-
TAGCCATCAGTCAC, MxA for: AGCCACTGGACTGAC-
GACTTG, MxA rev: AAATCACCACGGCTAACGGATAAG,
OAS1 for: AGAACTTACCTCTTGCCAAAGG, OAS1 rev:
GGACAAGGGATGTGAAAATTCC, CXCL10 for: GGAAG-
GTTAATGTTCATCATCCTAAGC, CXCL10 rev: TAGTAC-
CCTTGGAAGATGGGAAAG, CXCL11 for: GGATGAAAG-
GTGGGTGAAAGGAC, CXCL11 rev: AACGTGAAAGCAC-
TTTGTAAACTCC, GAPDH for: CACCCACTCCTCCACC-
TTTGAC, GAPDH rev: GTCCACCACCCTGTTGCTGTAG.
Primers used for hamster study: hamster CXCL10 for: AGA-
CAACAGTAACTCCAGTGACAAG, hamster CXCL10 rev: A-
GTGTAGCACCTCAGCGTAGC, murine GAPDH for: GC-
ATGGCCTTCCGTGTCC, murine GAPDH rev: TGTCAT-
CATACTTGGCAGGTTTCT. The relative expression repre-
sents the ratio of the number of copy of mRNA of interest versus
mRNA of GAPDH and expressed in relationship to the quantity
of RNA analyzed All calculations were done using the 2
DDCT
model of [51] and experiments were performed according to the
MIQE guideline [52].
ELISA analysis
Supernatants of mock and NiV-infected HUVECs were
collected 8, 24, 48, 72 h p.i. and used to quantify the induction
of CXCL10 using human IP-10 Immunoassay (Invitrogen
TM),
according to manufacturer’s instructions. All tests were performed
on 2 sets of 3 donors, in duplicates.
Immunohisotchemistry (IHC)
Autopsy brain tissue was obtained from 3 fatal acute Nipah
cases from the outbreak in Malaysia in 1999, fixed in 10%
buffered formalin and paraffin-embedded and from two control
brain tissues from patients that succumbed to non-neurological
diseases. Sections (4 mm) were deparaffinized with xylene and
rehydrated through graded alcoho la n dd i s t i l l e dw a t e r .A n t i g e n
retrieval was performed in 10 mM trisodium citrate buffer,
pH=6, using waterbath (99uC, 20 min). Slides were then
washed 3 times in PBS 16. Endogenous peroxidase was
blocked using H2O2, 3% in PBS, for 20 min at Room
temperature (RT). Slides were then washed 2 times in PBS
16 and additional blocking was performed using goat serum
(1:20 in PBS) for 20 min at RT. Primary rabbit anti-human
CXCL10 (Peprotech), was applied diluted at 4 mg/ml, over-
n i g h ta t4 uC. After 3 washes in PBS, slides were incubated with
secondary goat anti-rabbit conjugated with HRP (Promega)
1:500 for 1–2 hours at RT. Sections were then developed with
AEC kit (VECTOR) for 25 min, washed in distilled water and
counterstained with Harris hematoxylin solution (Sigma-
Aldrich) 1:3 in PBS, 30 s. After one wash in water (3 min)
sections were mounted with DakoCytomation faramount
aqueous mounting medium and coverslipped. Slides were
analysed using Axioscope microscope equipped with Zeiss
Axiovision software (Zeiss Geramny).
Statistical analysis
Data were expressed as mean6standard deviation (SD). Statistic
analyses were performed using Mann-Whitney U-test and Pearson
correlation test.
Supporting Information
Figure S1 Expression of the endothelial-specific mark-
ers. Von Willebrand Factor (VWF) and CD31 (PECAM-1) were
analyzed in 2
nd day HUVEC cultures by immunostaining with
anti-CD31 (green) and anti-VWF (red). Nuclei were stained with
DAPI (blue). Analysis was performed as described in Methods S1.
(TIF)
Methods S1 Supplementary methods.
(DOCX)
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